Utility of Next-Generation Sequencing for classification and prognostic prediction in diffuse large B-cell lymphoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046974

Enrollment

Unknown

Registered

2021-06-06

Start date

2021-06-05

Completion date

Unknown

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

lymphoma group:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients were diagnozed with DLBCL from 2014 to 2020 in the hematological department of our hospital. DLBCL tumor tissues were frozen in our biobank at the time of disease diagnosis.

Exclusion criteria

Exclusion criteria: 1. Special type of patients with diffuse large B, severe liver and kidney dysfunction, HIV infection, and other tumors; 2. Pregnant patients.

Design outcomes

Primary

Measure	Time frame
Progressiion free time;	—

Secondary

Measure	Time frame
Overall survival;	—

Countries

China

Contacts

Public ContactJin Jie

The First Affiliated Hospital, Zhejiang University College of Medicine

jiej0503@zju.edu.cn+86 57187236 898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026